欧洲移植诊断市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲移植诊断市场 – 行业趋势和 2029 年预测

  • Medical Devices
  • Published Report
  • Nov 2022
  • Europe
  • 350 页面
  • 桌子數: 421
  • 图号: 43

Europe Transplant Diagnostics Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –0
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 2,029.00
Diagram CAGR
%
Diagram Major Markets Players
  • Hologic
  • Biofortuna Limited
  • Takara Bio
  • BAG Diagnostics GmbH
  • Abbott Diagnostica Longwood SL

>欧洲移植诊断市场,按产品类型(移植诊断仪器、移植诊断软件、移植诊断试剂)、技术(基于 PCR 的分子测定、基于测序的分子测定)、移植类型(实体器官移植、干细胞移植、软组织移植、骨髓移植、其他移植)、应用(诊断应用、研究应用)、最终用户(研究实验室和学术机构、医院和移植中心、商业服务提供商、其他)、分销渠道(直接招标、零售销售和其他)行业趋势和预测到 2029 年。

欧洲移植诊断市场

欧洲移植诊断市场分析与洞察

移植诊断是一种诊断程序,通常分为移植前和移植后程序。它有助于分析患者的健康状况。如果避免这种情况,免疫功能低下的人有患上 HAI 或更糟情况的风险,这可能导致死亡。该程序是医疗保健专业人员和实验室专家之间的和谐合作,可确保更好的患者结果。此外,供体和受体 HLA 标记的紧密匹配也很重要。这增加了移植物存活的可能性,并最大限度地减少了免疫移植的严重并发症。全球人口中慢性病患病率的增加可能会在预测年内推动市场扩张。此外,干细胞疗法和个性化药物的使用越来越普遍。新诊断技术的使用改善了器官移植的医疗效果。通过在移植前匹配供体和受体的兼容性可以降低器官排斥率。

欧洲移植诊断市场

欧洲移植诊断市场

然而,PCR 和 NGS 诊断仪器相关程序的高成本是最重要的因素之一。因此,从长远来看,市场增长可能会受到阻碍。医疗设备的成本是可能对关键移植诊断设备供应商构成挑战的一个因素。

Data Bridge Market Research 分析称,预计到 2029 年,欧洲移植诊断市场价值将达到 29.3394 亿美元,预测期内复合年增长率为 6.2%。本市场报告还深入介绍了定价分析、专利分析和技术进步。

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020 (可定制至 2019-2014)

定量单位

收入(百万美元),定价(美元)

涵盖的领域

按产品类型(移植诊断仪器、移植诊断软件、移植诊断试剂)、技术(基于 PCR 的分子检测、基于测序的分子检测)、移植类型(实体器官移植、干细胞移植、软组织移植、骨髓移植、其他)、应用(诊断应用、研究应用)、最终用户(研究实验室和学术机构、医院和移植中心、商业服务提供商、其他)、分销渠道(直接招标、零售和其他)

覆盖国家

德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士及欧洲其他国家

涵盖的市场参与者

Hologic, Inc.、Biofortuna Limited、Takara Bio Inc.、BAG Diagnostics GmbH、Abbott、Diagnóstica Longwood SL、Adaptive Biotechnologies、NanoString、Arquer Diagnostics Ltd、CLONIT srl、Biotype GmbH、PathoNostics、altona Diagnostics GmbH、ELITechGroup、DiaSorin SpA、Horiba Ltd、Laboratory Corporation of America Holdings.、Randox Laboratories Ltd.、TransMedics、Thermo Fisher Scientific Inc.、Stryker、Bio-Rad Laboratories, Inc.、Zimmer Biomet、QIAGEN、F. Hoffmann-La Roche Ltd、BIOMÉRIEUX、CareDx Inc.、Illumina, Inc.、Luminex Corporation(DiaSorin Company 的子公司)、IMMUCOR 等

市场定义

移植诊断是器官和造血干细胞移植的免疫遗传学和组织相容性。这些诊断可帮助医疗保健专业人员确定潜在接受者和器官捐赠者之间的兼容性。它们用于各种学科,例如免疫遗传学、病理学和传染病等。移植诊断用于确定器官的捐赠者和接受者在移植前或移植后是否兼容。随着移植诊断的引入,可能导致器官衰竭的疾病的流行率(包括移植前和移植后的筛查)预计将激增。由于这些测试在验证移植程序的适用性方面具有许多优势,因此市场吸引了医疗保健专业人员的兴趣。器官移植是许多接受持续透析的终末期肾病患者最受欢迎的治疗选择之一。

此外,还可以研究涉及心脏、肝脏或骨髓的器官移植病例。尽管在许多情况下,肾衰竭与肝移植之间存在很强的关联,包括终末期肾病。分子诊断中的新转录组学、蛋白质组学和基因组学指标有助于更好地定制移植疗法并早期检测排斥事件。此外,市场参与者的战略举措、移植诊断的技术进步、高无菌保证和对医疗基础设施的不断投资增加了对移植诊断的需求。

欧洲移植诊断市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容:    

驱动程序

  • 移植手术数量不断增加

过去十年,由于重要器官衰竭发生率增加和移植后结果改善,全球对器官移植的需求迅速增加。对肾脏、心脏、肝脏和肺脏移植的需求非常高。饮酒、缺乏运动和药物滥用是器官衰竭的主要原因。活体器官移植的数量受到了 COVID -19疫情的影响。但活体器官移植数量在 2020 年增加了 14.2%。

此外,器官移植可提高患者的生存率和生活质量,对公共卫生和器官衰竭的社会经济负担产生重大积极影响。欧盟 (EU) 对器官移植采取相对统一和结构化的方法,拥有完善的国家计划、促进器官共享的国际系统和明确的交换政策,使欧洲在这一领域处于领先地位。

因此,全球移植手术数量的增加和成功移植数量的增加预计将推动欧洲移植诊断市场的发展。

  •  移植领域的技术进步不断提高

新技术正在迅速改变传统的器官移植方法。器官移植的主要挑战是如何最好地识别并尽可能消除终身免疫抑制的需要,以及如何扩大适合人体移植的捐赠者库。研究人员已经开发出一种先进的系统,通过欺骗捐赠器官,让它们认为它们仍在体内,可以延长运输时间。该系统使含氧血液流经器官,以延缓组织死亡。常温灌注机模拟人体,确保器官血流不断。该机器还可以输送药物或其他营养物质,使肝脏在移植前保持最佳状态。

此外,生物人工器官生产技术是一系列基于仿生原理可用于生产人体器官的使能技术。在过去十年中,各种器官制造技术的开发取得了重大进展。过去十年,单细胞 RNA 测序、纳米生物技术和 CRISPR-Cas9 基因编辑等新技术取得了巨大进步。然而,创造性地应用这些强大的新技术来改善临床移植才刚刚开始。有了这些工具,现在就有很好的机会在定义和提供所有器官移植的优化和个性化护理方面取得重大突破。

克制

  • 器官移植费用高昂

器官移植治疗采用技术先进的产品。这些产品的开发需要开发商进行严格的研究和开发。因此,程序和产品成本仍然很高,这相应地增加了测试成本。此外,器官移植费用昂贵,因为它们需要大量资源,需要高薪医生、交通和昂贵的药物。

此外,脱敏疗法也用于实现来自不相容供体的移植。然而,这种程序非常昂贵,并且可能伴有并发症和更差的长期结果。

因此,使用先进方式和技术产品进行移植和治疗的高成本将成为欧洲移植诊断市场增长的主要制约因素。

机会

  • 市场参与者的战略举措

欧洲移植诊断市场的崛起增加了对战略商业理念的需求。它包括合作伙伴关系、业务扩展和其他发展。对捐赠器官的需求激增大大增加了对移植诊断试剂盒的需求。计划中的战略使市场参与者能够与组织的职能活动保持一致,以实现既定目标。它指导公司的讨论和决策,以确定实现目标所需的资源和预算,从而提高运营效率。

这些战略举措,例如主要市场参与者的产品发布、协议和业务扩展,将促进市场增长,并有望成为欧洲移植诊断市场的机会。这些战略举措有望促进增长并改善公司的产品组合,最终带来更多收入。因此,市场参与者的这些战略举措可能有望成为帮助他们推动欧洲移植诊断市场的机会。

挑战

  • 器官移植面临的伦理挑战

重要器官衰竭发生率激增和器官供应不足导致器官供应与需求之间出现巨大差距。这一问题导致器官接受审批时间过长,死亡率上升。这些事件在过去几年发生,现在仍在继续,引发了许多伦理、道德和社会问题,涉及器官供应、器官分配方法以及使用活体捐献者作为志愿者(包括未成年人)。

报告不准确,捐赠的器官无法提供,而且很快就发现既不能减轻痛苦也不能延长生命的手术。

器官采购不足、宗教接受、脑死亡和与器官捐赠和移植有关的误解等问题仍然存在于许多道德个人和社区层面,甚至在医学界也是如此。伦理、文化和宗教性质的各个方面不应成为器官捐赠和移植行为的障碍——所有这些都是需要解决的问题。因此,器官移植过程中面临的道德挑战预计将挑战市场增长。

新冠肺炎疫情对欧洲移植诊断市场的影响

欧洲移植诊断市场受到 COVID-19 的严重影响。疫情期间,医院入院人数仅限于非必要治疗,诊所也暂时关闭。实施社交隔离、封锁人群和限制进入诊所极大地影响了市场。患者流量和转诊的放缓也影响了市场的增长。然而,由于先前实施的限制有所放松,市场将在疫情后继续增长。

制造商正在制定各种战略决策,以在新冠疫情后实现复苏。参与者正在开展多项研发活动、产品发布和战略合作,以改善欧洲移植诊断市场的技术和测试结果。

最新动态

  • 2022 年 8 月,QIAGEN 在《分子病理学杂志》上发表了一项外部协助的临床 NGS 解释验证研究,表明其临床决策支持软件 QIAGEN Clinical Insight Interpret One (QCI Interpret One) 与专家小组的一致性水平高于人工审阅者之间的一致性。该研究由 QDI 委托并由基因组学质量评估 (GenQA) 独立开展,调查了肿瘤患者样本报告的变异分类。这有助于公司验证其研究
  • 2022 年 1 月,Hoffmann-La Roche Ltd 推出了 Cobas Infinity edge,这是一款基于云的即时护理平台。借助其先进的技术,医疗保健从业者可以处理患者数据。这有助于该公司实现产品线的多样化

欧洲移植诊断市场范围

欧洲移植诊断市场细分为产品类型、技术、移植类型、应用、最终用户和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

产品类型

  • 移植诊断仪器
  • 移植诊断软件
  • 移植诊断试剂

根据产品类型,欧洲移植诊断市场分为移植诊断仪器、移植诊断软件、移植诊断试剂。

技术

  • 基于 PCR 的分子检测
  • 基于测序的分子检测

根据技术,欧洲移植诊断市场分为基于 PCR 的分子检测和基于测序的分子检测。

移植类型

根据移植类型,欧洲移植诊断市场分为实体器官移植、干细胞移植、软组织移植、骨髓移植和其他移植。

应用

  • 诊断应用
  • 研究应用

根据应用,欧洲移植诊断市场分为诊断应用和研究应用。

最终用户

  • 研究实验室和学术机构
  • 医院和移植中心
  • 商业服务提供商
  • 其他的

根据最终用户,欧洲移植诊断市场分为研究实验室和学术机构、医院和移植中心、商业服务提供商等。

分销渠道

  • 直接招标
  • 零售销售
  • 其他的

移植诊断市场

根据分销渠道,欧洲移植诊断市场分为直接招标、零售和其他。

欧洲移植诊断市场区域分析/见解

对欧洲移植诊断市场进行了分析,并按国家、产品类型、技术、移植类型、应用、最终用户和分销渠道提供了市场规模信息。

欧洲移植诊断市场涵盖的国家包括德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士和欧洲其他国家。

由于移植诊断手术的增加、新兴市场的需求不断增长以及医疗保健行业的扩张,德国预计将主导欧洲移植诊断市场。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战以及销售渠道的影响。

竞争格局和欧洲移植诊断市场份额分析

欧洲移植诊断市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对欧洲移植诊断市场的关注有关。

欧洲移植诊断市场的一些主要参与者包括 Hologic, Inc.、Biofortuna Limited、Takara Bio Inc.、BAG Diagnostics GmbH、Abbott、Diagnóstica Longwood SL、Adaptive Biotechnologies、NanoString、Arquer Diagnostics Ltd、CLONIT srl、Biotype GmbH、PathoNostics、altona Diagnostics GmbH、ELITechGroup、DiaSorin SpA、Horiba Ltd、Laboratory Corporation of America Holdings.、Randox Laboratories Ltd.、TransMedics、Thermo Fisher Scientific Inc.、Stryker、Bio-Rad Laboratories, Inc.、Zimmer Biomet、QIAGEN、F. Hoffmann-La Roche Ltd、BIOMÉRIEUX、CareDx Inc.、Illumina, Inc.、Luminex Corporation(DiaSorin Company 的子公司)和IMMUCOR 等。

研究方法:欧洲移植诊断市场

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析以及主要(行业专家)验证。除此之外,数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、欧洲与地区以及供应商份额分析。如有进一步询问,请要求分析师致电。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE TRANSPLANT DIAGNOSTICS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 SOURCE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 EPIDEMOLOGY

3.2 PESTEL_ANALYSIS

3.3 PORTER'S FIVE FORCE

3.4 TECHNOLOGICAL INNOVATIONS

4 EUROPE TRANSPLANT DIAGNOSTICS MARKET: REGULATIONS

5 KEY STRATEGIC INITIATIVES

6 INDUSTRIAL INSIGHTS:

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISING NUMBER OF TRANSPLANT PROCEDURES

7.1.2 INCREASE IN THE TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF TRANSPLANTS

7.1.3 RISING HEALTHCARE SPENDING

7.1.4 ADOPTION OF CROSS-MATCHING AND CHIMERISM TESTING DURING PRE- AND POST-TRANSPLANTATION

7.2 RESTRAINTS

7.2.1 HIGH COST OF ORGAN TRANSPLANTATION

7.2.2 THE RISKS AND DIFFICULTIES OF ORGAN TRANSPLANTATION

7.3 OPPORTUNITIES

7.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS

7.3.2 RISE IN PUBLIC, PRIVATE, AND GOVERNMENT FUNDING FOR ORGAN TRANSPLANTATION

7.3.3 SURGE IN AWARENESS ABOUT THE IMPORTANCE OF ORGAN TRANSPLANTATION

7.4 CHALLENGES

7.4.1 ETHICAL CHALLENGES FACED DURING ORGAN TRANSPLANTATION

7.4.2 LACK OF ORGAN DONORS OR GAP BETWEEN ORGAN DONORS AND ORGANS NEEDED ANNUALLY

8 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 TRANSPLANT DIAGNOSTIC INSTRUMENTS

8.2.1 AUTOMATED PIPETTORS & DISPENSERS

8.2.2 AUTOMATED SYSTEMS

8.2.2.1 NUCLEIC ACID EXTRACTION SYSTEM

8.2.2.2 PCR SETUP

8.2.2.3 OTHERS

8.2.3 NGS INSTRUMENTS

8.2.4 READERS & ANALYZERS

8.2.5 TRANSPLANT DIAGNOSTIC KITS

8.2.5.1 ASPERGILLUS SPP KITS

8.2.5.2 P. JIROVECII KITS

8.2.5.3 CMV KITS

8.2.5.4 EBV KITS

8.2.5.5 BKV KITS

8.2.5.6 VZV KITS

8.2.5.7 HSV1 KITS

8.2.5.8 HSV2 KITS

8.2.5.9 PARVOVIRUS B19 KITS

8.2.5.10 ADENOVIRUS KITS

8.2.5.11 ENTEROVIRUS KITS

8.2.5.12 JCV KITS

8.2.5.13 HHV6 KITS

8.2.5.14 HHV7 KITS

8.2.5.15 HHV8 KITS

8.2.5.16 TOXOPLASMA GONDII KITS

8.2.5.17 HEPATITIS E KITS

8.2.5.18 OTHER KITS

8.2.6 OTHER KITS

8.3 TRANSPLANT DIAGNOSTIC SOFTWARE’S

8.3.1 DNA SOFTWARE

8.3.2 NGS SOFTWARE

8.3.3 DATA MANAGEMENT SOFTWARE

8.3.4 OTHER SOFTWARE’S

8.4 TRANSPLANT DIAGNOSTIC REAGENTS

8.4.1 MONOCLONAL ANTIBODIES

8.4.2 CYTOTOXIC CONTROLS

8.4.3 HUMAN SERUM

8.4.4 OTHER REAGENTS

9 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY

9.1 OVERVIEW

9.2 PCR-BASED MOLECULAR ASSAYS

9.2.1 REAL TIME PCR

9.2.2 SEQUENCE-SPECIFIC PRIMER-PCR

9.2.3 SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR

9.2.4 RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)

9.2.5 OTHER-PCR BASED MOLECULAR ASSAYS

9.3 SEQUENCING-BASED MOLECULAR ASSAYS

9.3.1 SANGER SEQUENCING

9.3.2 NEXT GENERATION SEQUENCING

9.3.3 OTHER SEQUENCING-BASED MOLECULAR ASSAYS.

10 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE

10.1 OVERVIEW

10.2 SOLID ORGAN TRANSPLANTATION

10.2.1 KIDNEY TRANSPLANTATION

10.2.2 LIVER TRANSPLANTATION

10.2.3 HEART TRANSPLANTATION

10.2.4 LUNG TRANSPLANTATION

10.2.5 PANCREAS TRANSPLANTATION

10.2.6 OTHER ORGAN TRANSPLANTATIONS

10.3 STEM CELL TRANSPLANTATION

10.3.1 BONE MARROW TRANSPLANT (BMT)

10.3.2 PERIPHERAL BLOOD STEM CELL TRANSPLANT

10.3.3 CORD BLOOD TRANSPLANT

10.3.4 OTHER STEM CELL TRANSPLANTS

10.4 SOFT TISSUE TRANSPLANTATION

10.4.1 SKIN GRAFT

10.4.2 CARTILAGE TRANSPLANTATION

10.4.3 ADRENAL AUTOGRAFTING

10.4.4 OTHER SOFT TISSUE TRANSPLANTATION.

10.5 BONE MARROW TRANSPLANTATION

10.5.1 AUTOLOGOUS BONE MARROW TRANSPLANT

10.5.2 ALLOGENEIC BONE MARROW TRANSPLANT

10.5.3 UMBILICAL CORD BLOOD TRANSPLANT.

10.6 OTHERS

11 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 DIAGNOSTIC APPLICATIONS

11.2.1 TRANSPLANT DIAGNOSTIC INSTRUMENT

11.2.1.1 AUTOMATED PIPETTORS & DISPENSERS

11.2.1.2 AUTOMATED SYSTEMS

11.2.1.3 NGS INSTRUMENTS

11.2.1.4 READERS & ANALYZERS

11.2.1.5 TRANSPLANT DIAGNOSTIC KITS

11.2.1.6 OTHERS

11.2.2 TRANSPLANT DIAGNOSTIC SOFTWARE

11.2.2.1 DNA SOFTWARE

11.2.2.2 NGS SOFTWARE

11.2.2.3 DATA MANAGEMENT SOFTWARE

11.2.2.4 OTHER SOFTWARES

11.2.3 TRANSPLANT DIAGNOSTIC REAGENT

11.2.3.1 MONOCLONAL ANTIBODIES

11.2.3.2 CYTOTOXIC CONTROLS

11.2.3.3 HUMAN SERUM

11.2.3.4 OTHER REAGENTS

11.3 RESEARCH APPLICATIONS

11.3.1 TRANSPLANT DIAGNOSTIC INSTRUMENT

11.3.1.1 AUTOMATED PIPETTORS & DISPENSERS

11.3.1.2 AUTOMATED SYSTEMS

11.3.1.3 NGS INSTRUMENTS

11.3.1.4 READERS & ANALYZERS

11.3.1.5 TRANSPLANT DIAGNOSTIC KITS

11.3.1.6 OTHERS

11.3.2 TRANSPLANT DIAGNOSTIC SOFTWARE

11.3.2.1 DNA SOFTWARE

11.3.2.2 NGS SOFTWARE

11.3.2.3 DATA MANAGEMENT SOFTWARE

11.3.2.4 OTHER SOFTWARES

11.3.3 TRANSPLANT DIAGNOSTIC REAGENT

11.3.3.1 MONOCLONAL ANTIBODIES

11.3.3.2 CYTOTOXIC CONTROLS

11.3.3.3 HUMAN SERUM

11.3.3.4 OTHER REAGENTS

12 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS AND TRANSPLANT CENTERS

12.3 COMMERCIAL SERVICE PROVIDERS

12.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES

12.5 OTHERS

13 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 RETAIL SALES

13.4 OTHERS

14 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REGION

14.1 EUROPE

14.1.1 GERMANY

14.1.2 FRANCE

14.1.3 U.K.

14.1.4 ITALY

14.1.5 RUSSIA

14.1.6 SPAIN

14.1.7 TURKEY

14.1.8 NETHERLANDS

14.1.9 SWITZERLAND

14.1.10 BELGIUM

14.1.11 REST OF EUROPE

15 EUROPE TRANSPLANT DIAGNOSTICS MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: EUROPE

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 ABBOTT

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 COMPANY SHARE ANALYSIS

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENTS

17.2 THERMO FISHER SCIENTIFIC INC.

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 COMPANY SHARE ANALYSIS

17.2.4 PRODUCT PORTFOLIO

17.2.5 RECENT DEVELOPMENTS

17.3 F. HOFFMANN LA ROCHE LTD

17.3.1 COMPANY SNAPSHOT

17.3.2 REVENUE ANALYSIS

17.3.3 COMPANY SHARE ANALYSIS

17.3.4 PRODUCT PORTFOLIO

17.3.5 RECENT DEVELOPMENT

17.4 TAKARA BIO INC.

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 COMPANY SHARE ANALYSIS

17.4.4 PRODUCT PORTFOLIO

17.4.5 RECENT DEVELOPMENTS

17.5 HOLOGIC, INC

17.5.1 COMPANY SNAPSHOT

17.5.2 REVENUE ANALYSIS

17.5.3 COMPANY SHARE ANALYSIS

17.5.4 PRODUCT PORTFOLIO

17.5.5 RECENT DEVELOPMENTS

17.6 ADAPTIVE BIOTECHNOLOGIES

17.6.1 COMPANY SNAPSHOT

17.6.2 REVENUE ANALYSIS

17.6.3 PRODUCT PORTFOLIO

17.6.4 RECENT DEVELOPMENT

17.7 ALTONA DIAGNOSTICS

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENTS

17.8 ARQUER DIAGNOSTICS LTD

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENTS

17.9 BAG DIAGNOSTICS GMBH

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENTS

17.1 BIOFORTUNA LIMITED

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENT

17.11 BIOMÉRIEUX

17.11.1 COMPANY SNAPSHOT

17.11.2 REVENUE ANALYSIS

17.11.3 PRODUCT PORTFOLIO

17.11.4 RECENT DEVELOPMENTS

17.12 BIO-RAD LABORATORIES, INC.

17.12.1 COMPANY SNAPSHOT

17.12.2 REVENUE ANALYSIS

17.12.3 PRODUCT PORTFOLIO

17.12.4 RECENT DEVELOPMENT

17.13 BIOTYPE GMBH

17.13.1 COMPANY SNAPSHOT

17.13.2 PRODUCT PORTFOLIO

17.13.3 RECENT DEVELOPMENTS

17.14 CAREDX INC.

17.14.1 COMPANY SNAPSHOT

17.14.2 REVENUE ANALYSIS

17.14.3 PRODUCT PORTFOLIO

17.14.4 RECENT DEVELOPMENTS

17.15 CLONIT SRL

17.15.1 COMPANY SNAPSHOT

17.15.2 PRODUCT PORTFOLIO

17.15.3 RECENT DEVELOPMENT

17.16 DIAGNOSTICA LONGWOOD SL

17.16.1 COMPANY SNAPSHOT

17.16.2 PRODUCT PORTFOLIO

17.16.3 RECENT DEVELOPMENTS

17.17 DIASORIN S.P.A.

17.17.1 COMPANY SNAPSHOT

17.17.2 REVENUE ANALYSIS

17.17.3 PRODUCT PORTFOLIO

17.17.4 RECENT DEVELOPMENT

17.18 ELITECHGROUP

17.18.1 COMPANY SNAPSHOT

17.18.2 PRODUCT PORTFOLIO

17.18.3 RECENT DEVELOPMENTS

17.19 EUROFINS VIRACOR

17.19.1 COMPANY SNAPSHOT

17.19.2 PRODUCT PORTFOLIO

17.19.3 RECENT DEVELOPMENTS

17.2 HORIBA LTD

17.20.1 COMPANY SNAPSHOT

17.20.2 REVENUE ANALYSIS

17.20.3 PRODUCT PORTFOLIO

17.20.4 RECENT DEVELOPMENT

17.21 ILLUMINA, INC.

17.21.1 COMPANY SNAPSHOT

17.21.2 REVENUE ANALYSIS

17.21.3 PRODUCT PORTFOLIO

17.21.4 RECENT DEVELOPMENTS

17.22 IMMUCOR

17.22.1 COMPANY SNAPSHOT

17.22.2 PRODUCT PORTFOLIO

17.22.3 RECENT DEVELOPMENTS

17.23 LABORATORY CORPORATION OF AMERICA HOLDINGS.

17.23.1 COMPANY SNAPSHOT

17.23.2 REVENUE ANALYSIS

17.23.3 PRODUCT PORTFOLIO

17.23.4 RECENT DEVELOPMENTS

17.24 LUMINEX CORPORATION. (A SUBSIDIARY OF DIASORIN)

17.24.1 COMPANY SNAPSHOT

17.24.2 REVENUE ANALYSIS

17.24.3 PRODUCT PORTFOLIO

17.24.4 RECENT DEVELOPMENT

17.25 NANOSTRING

17.25.1 COMPANY SNAPSHOT

17.25.2 REVENUE ANALYSIS

17.25.3 PRODUCT PORTFOLIO

17.25.4 RECENT DEVELOPMENT

17.26 PATHONOSTICS

17.26.1 COMPANY SNAPSHOT

17.26.2 PRODUCT PORTFOLIO

17.26.3 RECENT DEVELOPMENTS

17.27 PRESERVATION SOLUTIONS, INC.

17.27.1 COMPANY SNAPSHOT

17.27.2 PRODUCT PORTFOLIO

17.27.3 RECENT DEVELOPMENTS

17.28 QIAGEN

17.28.1 COMPANY SNAPSHOT

17.28.2 REVENUE ANALYSIS

17.28.3 PRODUCT PORTFOLIO

17.28.4 RECENT DEVELOPMENTS

17.29 RANDOX LABORATORIES LTD.

17.29.1 COMPANY SNAPSHOT

17.29.2 PRODUCT PORTFOLIO

17.29.3 RECENT DEVELOPMENTS

17.3 STRYKER

17.30.1 COMPANY SNAPSHOT

17.30.2 REVENUE ANALYSIS

17.30.3 PRODUCT PORTFOLIO

17.30.4 RECENT DEVELOPMENT

17.31 TRANSMEDICS

17.31.1 COMPANY SNAPSHOT

17.31.2 REVENUE ANALYSIS

17.31.3 PRODUCT PORTFOLIO

17.31.4 RECENT DEVELOPMENTS

17.32 TRANSONIC.

17.32.1 COMPANY SNAPSHOT

17.32.2 PRODUCT PORTFOLIO

17.32.3 RECENT DEVELOPMENT

17.33 ZIMMER BIOMET

17.33.1 COMPANY SNAPSHOT

17.33.2 REVENUE ANALYSIS

17.33.3 PRODUCT PORTFOLIO

17.33.4 RECENT DEVELOPMENTS

18 QUESTIONNAIRE

19 RELATED REPORTS

表格列表

TABLE 1 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 EUROPE TRANSPLANT DIAGNOSTIC INSTRUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 EUROPE TRANSPLANT DIAGNOSTIC INSTRUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 4 EUROPE AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 5 EUROPE TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 EUROPE TRANSPLANT DIAGNOSTIC SOFTWARE’S IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 EUROPE TRANSPLANT DIAGNOSTIC SOFTWARE’S IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 8 EUROPE TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 EUROPE TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 10 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 11 EUROPE PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 EUROPE PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 13 EUROPE SEQUENCING-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 EUROPE SEQUENCING-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 15 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 16 EUROPE SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 EUROPE SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 18 EUROPE STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 20 EUROPE SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 EUROPE SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 22 EUROPE BONE MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 EUROPE BONE MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 24 EUROPE OTHERS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 EUROPE DIAGNOSTIC APPLICATIONS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 EUROPE DIAGNOSTIC APPLICATIONS IN EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 28 EUROPE TRANSPLANT DIAGNOSTIC INSTRUMENTS IN EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 29 EUROPE TRANSPLANT DIAGNOSTIC SOFTWARE IN EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 30 EUROPE TRANSPLANT DIAGNOSTIC REAGENT IN EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 31 EUROPE RESEARCH APPLICATIONS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 EUROPE RESEARCH APPLICATIONS IN EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 33 EUROPE TRANSPLANT DIAGNOSTIC INSTRUMENTS IN EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 34 EUROPE TRANSPLANT DIAGNOSTIC SOFTWARE IN EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 35 EUROPE TRANSPLANT DIAGNOSTIC REAGENT IN EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 36 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 37 EUROPE HOSPITALS AND TRANSPLANT CENTERS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 EUROPE COMMERCIAL SERVICE PROVIDERS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 EUROPE RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 EUROPE OTHERS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 42 EUROPE DIRECT TENDER IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 EUROPE RETAIL SALES IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 EUROPE OTHERS IN TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 EUROPE TRANSPLANT DIAGNOSTIC MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 46 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 47 EUROPE TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 48 EUROPE AUTOMATED PIPETTORS & DISPENSERS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 49 EUROPE TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 50 EUROPE TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 51 EUROPE TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 52 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 53 EUROPE PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 54 EUROPE SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 55 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 56 EUROPE SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 57 EUROPE STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 58 EUROPE SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 59 EUROPE BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 60 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 61 EUROPE DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 62 EUROPE TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 63 EUROPE TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 64 EUROPE TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 65 EUROPE RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 66 EUROPE TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 67 EUROPE TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 68 EUROPE TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 69 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 70 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 71 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 72 GERMANY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 73 GERMANY AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 74 GERMANY AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 75 GERMANY AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 76 GERMANY TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 77 GERMANY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 78 GERMANY TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 79 GERMANY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 80 GERMANY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 81 GERMANY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 82 GERMANY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 83 GERMANY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 84 GERMANY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 85 GERMANY TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 86 GERMANY TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 87 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 88 GERMANY PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 89 GERMANY SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 90 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 91 GERMANY SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 92 GERMANY STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 93 GERMANY SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 94 GERMANY BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 95 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 96 GERMANY DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 97 GERMANY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 98 GERMANY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 99 GERMANY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 100 GERMANY RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 101 GERMANY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 102 GERMANY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 103 GERMANY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 104 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 105 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 106 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 107 FRANCE TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 108 FRANCE AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 109 FRANCE AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 110 FRANCE AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 111 FRANCE TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 112 FRANCE TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 113 FRANCE TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 114 FRANCE TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 115 FRANCE TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 116 FRANCE TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 117 FRANCE TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 118 FRANCE TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 119 FRANCE TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 120 FRANCE TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 121 FRANCE TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 122 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 123 FRANCE PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 124 FRANCE SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 125 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 126 FRANCE SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 127 FRANCE STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 128 FRANCE SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 129 FRANCE BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 130 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 FRANCE DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 132 FRANCE TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 133 FRANCE TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 134 FRANCE TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 135 FRANCE RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 136 FRANCE TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 137 FRANCE TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 138 FRANCE TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 139 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 140 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 141 U.K. TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 142 U.K. TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 143 U.K. AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 144 U.K. AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 145 U.K. AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 146 U.K. TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 147 U.K. TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 148 U.K. TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 149 U.K. TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 150 U.K. TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 151 U.K. TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 152 U.K. TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 153 U.K. TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 154 U.K. TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 155 U.K. TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 156 U.K. TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 157 U.K. TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 158 U.K. PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 159 U.K. SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 160 U.K. TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 161 U.K. SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 162 U.K. STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 163 U.K. SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 164 U.K. BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 165 U.K. TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 166 U.K. DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 167 U.K. TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 168 U.K. TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 169 U.K. TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 170 U.K. RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 171 U.K. TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 172 U.K. TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 173 U.K. TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 174 U.K. TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 175 U.K. TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 176 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 177 ITALY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 178 ITALY AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 179 ITALY AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 180 ITALY AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 181 ITALY TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 182 ITALY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 183 ITALY TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 184 ITALY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 185 ITALY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 186 ITALY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 187 ITALY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 188 ITALY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 189 ITALY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 190 ITALY TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 191 ITALY TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 192 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 193 ITALY PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 194 ITALY SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 195 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 196 ITALY SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 197 ITALY STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 198 ITALY SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 199 ITALY BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 200 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 201 ITALY DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 202 ITALY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 203 ITALY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 204 ITALY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 205 ITALY RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 206 ITALY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 207 ITALY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 208 ITALY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 209 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 210 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 211 RUSSIA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 212 RUSSIA TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 213 RUSSIA AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 214 RUSSIA AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 215 RUSSIA AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 216 RUSSIA TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 217 RUSSIA TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 218 RUSSIA TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 219 RUSSIA TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 220 RUSSIA TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 221 RUSSIA TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 222 RUSSIA TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 223 RUSSIA TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 224 RUSSIA TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 225 RUSSIA TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 226 RUSSIA TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 227 RUSSIA TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 228 RUSSIA PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 229 RUSSIA SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 230 RUSSIA TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 231 RUSSIA SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 232 RUSSIA STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 233 RUSSIA SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 234 RUSSIA BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 235 RUSSIA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 236 RUSSIA DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 237 RUSSIA TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 238 RUSSIA TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 239 RUSSIA TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 240 RUSSIA RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 241 RUSSIA TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 242 RUSSIA TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 243 RUSSIA TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 244 RUSSIA TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 245 RUSSIA TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 246 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 247 SPAIN TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 248 SPAIN AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 249 SPAIN AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 250 SPAIN AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 251 SPAIN TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 252 SPAIN TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 253 SPAIN TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 254 SPAIN TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 255 SPAIN TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 256 SPAIN TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 257 SPAIN TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 258 SPAIN TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 259 SPAIN TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 260 SPAIN TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 261 SPAIN TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 262 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 263 SPAIN PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 264 SPAIN SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 265 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 266 SPAIN SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 267 SPAIN STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 268 SPAIN SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 269 SPAIN BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 270 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 271 SPAIN DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 272 SPAIN TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 273 SPAIN TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 274 SPAIN TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 275 SPAIN RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 276 SPAIN TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 277 SPAIN TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 278 SPAIN TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 279 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 280 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 281 TURKEY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 282 TURKEY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 283 TURKEY AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 284 TURKEY AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 285 TURKEY AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 286 TURKEY TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 287 TURKEY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 288 TURKEY TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 289 TURKEY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 290 TURKEY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 291 TURKEY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 292 TURKEY TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 293 TURKEY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 294 TURKEY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 295 TURKEY TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 296 TURKEY TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 297 TURKEY TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 298 TURKEY PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 299 TURKEY SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 300 TURKEY TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 301 TURKEY SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 302 TURKEY STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 303 TURKEY SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 304 TURKEY BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 305 TURKEY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 306 TURKEY DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 307 TURKEY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 308 TURKEY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 309 TURKEY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 310 TURKEY RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 311 TURKEY TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 312 TURKEY TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 313 TURKEY TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 314 TURKEY TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 315 TURKEY TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 316 NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 317 NETHERLANDS TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 318 NETHERLANDS AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 319 NETHERLANDS AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 320 NETHERLANDS AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 321 NETHERLANDS TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 322 NETHERLANDS TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 323 NETHERLANDS TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 324 NETHERLANDS TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 325 NETHERLANDS TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 326 NETHERLANDS TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 327 NETHERLANDS TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 328 NETHERLANDS TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 329 NETHERLANDS TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 330 NETHERLANDS TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 331 ETHERLANDS TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 332 NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 333 NETHERLANDS PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 334 NETHERLANDS SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 335 NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 336 NETHERLANDS SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 337 NETHERLANDS STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 338 NETHERLANDS SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 339 NETHERLANDS BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 340 NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 341 NETHERLANDS DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 342 NETHERLANDS TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 343 NETHERLANDS TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 344 NETHERLANDS TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 345 NETHERLANDS RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 346 NETHERLANDS TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 347 NETHERLANDS TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 348 NETHERLANDS TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 349 NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 350 NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 351 SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 352 SWITZERLAND TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 353 SWITZERLAND AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 354 SWITZERLAND AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 355 SWITZERLAND AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 356 SWITZERLAND TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 357 SWITZERLAND TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 358 SWITZERLAND TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 359 SWITZERLAND TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 360 SWITZERLAND TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 361 SWITZERLAND TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 362 SWITZERLAND TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 363 SWITZERLAND TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 364 SWITZERLAND TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 365 SWITZERLAND TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 366 SWITZERLAND TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 367 SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 368 SWITZERLAND PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 369 SWITZERLAND SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 370 SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 371 SWITZERLAND SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 372 SWITZERLAND STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 373 SWITZERLAND SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 374 SWITZERLAND BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 375 SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 376 SWITZERLAND DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 377 SWITZERLAND TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 378 SWITZERLAND TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 379 SWITZERLAND TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 380 SWITZERLAND RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 381 SWITZERLAND TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 382 SWITZERLAND TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 383 SWITZERLAND TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 384 SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 385 SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 386 BELGIUM TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 387 BELGIUM TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 388 BELGIUM AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 VOLUME (UNITS)

TABLE 389 BELGIUM AUTOMATED PIPETTORS & DISPENSERS, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 390 BELGIUM AUTOMATED SYSTEMS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 391 BELGIUM TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 392 BELGIUM TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 393 BELGIUM TRANSPLANT DIAGNOSTIC INSTUMENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 394 BELGIUM TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 395 BELGIUM TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 396 BELGIUM TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 397 BELGIUM TRANSPLANT DIAGNOSTIC KITS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 398 BELGIUM TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 399 BELGIUM TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 400 BELGIUM TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 VOLUMES (UNITS)

TABLE 401 BELGIUM TRANSPLANT DIAGNOSTIC REAGENTS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 ASP (USD)

TABLE 402 BELGIUM TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 403 BELGIUM PCR-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 404 BELGIUM SEQUENCE-BASED MOLECULAR ASSAYS IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 405 BELGIUM TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 406 BELGIUM SOLID ORGAN TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 407 BELGIUM STEM CELL TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 408 BELGIUM SOFT TISSUE TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 409 BELGIUM BONE-MARROW TRANSPLANTATION IN TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2020-2029 (USD MILLION)

TABLE 410 BELGIUM TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 411 BELGIUM DIAGNOSTICS APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 412 BELGIUM TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 413 BELGIUM TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 414 BELGIUM TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 415 BELGIUM RESEARCH APPLICATIONS TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 416 BELGIUM TRANSPLANT DIAGNOSTICS INSTRUMENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 417 BELGIUM TRANSPLANT DIAGNOSTIC SOFTWARE IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 418 BELGIUM TRANSPLANT DIAGNOSTIC REAGENT IN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 419 BELGIUM TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 420 BELGIUM TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 421 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 EUROPE TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 EUROPE TRANSPLANT DIAGNOSTICS MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE TRANSPLANT DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE TRANSPLANT DIAGNOSTICS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE TRANSPLANT DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE TRANSPLANT DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE TRANSPLANT DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 EUROPE TRANSPLANT DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE TRANSPLANT DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 11 INCREASING USE OF TRANSPLANT DIAGNOSTICS IS EXPECTED TO DRIVE THE EUROPE TRANSPLANT DIAGNOSTICS MARKET IN THE FORECAST PERIOD

FIGURE 12 TRANSPLANT DIAGNOSTIC INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE TRANSPLANT DIAGNOSTICS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE TRANSPLANT DIAGNOSTICS MARKET

FIGURE 14 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2021

FIGURE 15 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 16 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 17 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 18 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY TECHNOLOGY, 2021

FIGURE 19 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY TECHNOLOGY, 2022-2029 (USD MILLION)

FIGURE 20 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY TECHNOLOGY, CAGR (2022-2029)

FIGURE 21 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY TECHNOLOGY, LIFELINE CURVE

FIGURE 22 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY TRANSPLANT TYPE, 2021

FIGURE 23 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY TRANSPLANT TYPE, 2022-2029 (USD MILLION)

FIGURE 24 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY TRANSPLANT TYPE, CAGR (2022-2029)

FIGURE 25 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY TRANSPLANT TYPE, LIFELINE CURVE

FIGURE 26 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2021

FIGURE 27 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 28 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 29 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY END USER, 2021

FIGURE 31 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY END USER, 2022-2029 (USD MILLION)

FIGURE 32 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY END USER, CAGR (2022-2029)

FIGURE 33 EUROPE TRANSPLANT DIAGNOSTICS MARKET : BY END USER, LIFELINE CURVE

FIGURE 34 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 35 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 36 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 37 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 EUROPE TRANSPLANT DIAGNOSTICS MARKET: SNAPSHOT (2021)

FIGURE 39 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY COUNTRY (2021)

FIGURE 40 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 41 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 42 EUROPE TRANSPLANT DIAGNOSTICS MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 43 EUROPE TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe Transplant Diagnostics Market is projected to grow at a CAGR of 6.2% during the forecast period by 2029.
The future market value of the Europe Transplant Diagnostics Market is expected to reach USD 2,933.94 million by 2029.
The major players in the Europe Transplant Diagnostics Market are Hologic, Inc., Biofortuna Limited, Takara Bio Inc., BAG Diagnostics GmbH, Abbott, Diagnóstica Longwood SL, Adaptive Biotechnologies, NanoString, Arquer Diagnostics Ltd, CLONIT srl, Biotype GmbH, PathoNostics, altona Diagnostics GmbH, etc.
The countries covered in the Europe Transplant Diagnostics Market are Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and the rest of Europe.